- 4.8Impact Factor
- 9.2CiteScore
- 20 daysTime to First Decision
Special Issues
Biomolecules publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Advances in Nano-Based Drug Delivery Systems
Deadline: 1 June 2026
Aldehyde Metabolism and Innate Immune Signaling in Cardiovascular Disease: From Pathogenesis to Regeneration
Deadline: 1 June 2026
Emerging Bioactives from Underexplored Botanical Sources and By-Products for Food Applications
Deadline: 1 June 2026
Tissue Calcification in Normal and Pathological Environments
Deadline: 31 May 2026
Redox Balance and Proteostasis Surveillance in Neurodegenerative Disorders
Deadline: 31 May 2026
Bioactive Molecules in the Control of Oxidative Stress and Oxidative Stress-Related Diseases
Deadline: 31 May 2026
Recent Advances in RNA Editing and Modification
Deadline: 31 May 2026
The Structure and Function of Neurotransmitter Receptors and Transporters: From Molecular Biology to Translational Research
Deadline: 31 May 2026
Oxidative Stress and Inflammation in Aging and Cancer: Biological Bases, Therapeutic Strategies and Opportunities
Deadline: 31 May 2026
Nonalcoholic Fatty Liver Disease: From Molecular Mechanisms to Therapeutic Approaches
Deadline: 31 May 2026
Liver Damage and Associated Metabolic Disorders
Deadline: 31 May 2026
Identifying New Therapeutic Targets for Psychiatric Disease Using Transcriptomics and Epigenomics
Deadline: 31 May 2026
of 100

